Johnson Celebrates a New Era in UK-India Relations After Virtual Summit with Modi | India News
LONDON: British Prime Minister Boris johnson on Tuesday declared a new era in relations between the United Kingdom and India after a virtual summit with the prime minister Narendra modi, which culminated in the agreement of the two leaders on a ‘Roadmap 2030’ as a framework to strengthen ties in health, climate, trade, education, science and technology, and defense.
Downing Street said the two prime ministers have pledged to achieve a “quantum leap” in the relationship between the United Kingdom and India and that India has raised the status of its relationship with the United Kingdom to a “Comprehensive Strategic Partnership”, the first European country to obtain this status.
An Enhanced Trade Partnership, which had been previously announced, was reiterated as the starting point for negotiating a Free Trade Agreement (FTA) in the future, with the ambition to double bilateral trade over the next decade.
“The agreements we have made today mark the beginning of a new era in the UK-India relationship,” Johnson said.
“The UK and India share many core values. The UK is one of the oldest democracies and India is the largest in the world. We are both committed members of the Commonwealth. And there is a living bridge that unites the people of our countries, ”he said.
“In the past week, the British have joined thousands to support our Indian friends during this terrible time in a demonstration of the deep connection between the UK and India. This connection will only grow over the next decade as we make together to tackle the world’s biggest problems and improve the lives of our people, ”added Johnson.
The ‘Roadmap 2030’, to be published in full by the Foreign, Commonwealth and Development Office (FCDO) and agreed between the two parties, includes plans to expand the UK-India healthcare partnership to improve global health security and resilience to pandemics. This includes strengthening international supply chains to ensure that medicines, vaccines and other critical medical products reach those who need them most.